首页> 美国卫生研究院文献>OncoTargets and therapy >rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese population
【2h】

rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese population

机译:let-7 microRNA结合位点内的rs712多态性可能与中国人群大肠癌的发生和发展有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

rs712 within 3′-untranslated region of KRAS can affect the specific binding between the mRNA and its targeted microRNAs, leading to the activation of KRAS oncogene. However, the possible association between the locus and susceptibility to colorectal cancer (CRC) remains unclear. We investigated genotypes of the locus in 586 cases and 476 controls to explore the possible association between them. Results of our case–control study showed that genotypes TT (6.5% vs 2.5%, P=0.002, adjusted odds ratio [OR] =2.810, 95% confidence interval [CI] =1.342–5.488) and GT/TT (36.5% vs 30.5%, P=0.038, adjusted OR =1.342, 95% CI =1.030–1.712) and allele T (21.5% vs 6.5%, P=0.004, adjusted OR =1.328, 95% CI =1.105–1.722) of rs712 were significantly associated with an increased risk of CRC, and the significant association was also observed in the recessive model (TT vs GG/GT, 6.5% vs 2.5%, P=0.003, adjusted OR =0.372, 95% CI =0.191–0.725). However, there was no association between genotype GT and risk of CRC (30.0% vs 28.0%, P=0.235, adjusted OR =1.210, 95% CI =0.903–1.548). Furthermore, genotype GT (P=0.003) and allele T (P=0.003) were significantly associated with poor differentiation, and genotypes GT and TT and allele T were significantly associated with tumor-node-metastases stage III (P=0.001 for GT vs GG, P<0.001 for TT vs GG, and P<0.001 for T vs G) and node metastasis (P<0.001 for GT vs GG, P=0.001 for TT vs GG, and P<0.001 for T vs G), respectively. These findings indicated that allele T and genotypes TT and GT/TT of rs712 might be susceptible factors for CRC, and mutated allele and genotypes of the locus might predict a poor clinical outcome in Chinese population.
机译:KRAS 3'-非翻译区域内的rs712可影响mRNA及其靶向微RNA之间的特异性结合,从而导致KRAS癌基因的激活。但是,目前尚不清楚该基因座与大肠癌易感性之间的可能关联。我们调查了586个病例和476个对照的基因座基因型,以探讨它们之间的可能关联。我们的病例对照研究结果表明,基因型TT(6.5%vs 2.5%,P = 0.002,调整后的优势比[OR] = 2.810,95%置信区间[CI] = 1.342–5.488)和GT / TT(36.5%)。 vs rs712的30.5%,P = 0.038,调整后的OR = 1.342,95%CI = 1.030–1.712)和等位基因T(21.5%vs 6.5%,P = 0.004,调整后的OR = 1.328,95%CI = 1.105–1.722)与CRC风险增加显着相关,并且在隐性模型中也观察到显着相关性(TT vs GG / GT,6.5%vs 2.5%,P = 0.003,校正后的OR = 0.372,95%CI = 0.191–0.725 )。但是,基因型GT与CRC风险之间没有关联(30.0%对28.0%,P = 0.235,校正OR = 1.210,95%CI = 0.903–1.548)。此外,基因型GT(P = 0.003)和等位基因T(P = 0.003)与不良的分化显着相关,基因型GT和TT和等位基因T与III期肿瘤淋巴结转移密切相关(GT vs.P = 0.001)。 GG,TT vs GG P <0.001,T vs G P <0.001)和淋巴结转移(GT vs GG P <0.001,TT vs GG P = 0.001,T vs G P <0.001) 。这些发现表明rs712的等位基因T和基因型TT和GT / TT可能是CRC的易感因素,并且等位基因的突变等位基因和基因型可能预示中国人群的临床结局较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号